4
Changes in Ownership
Taysha Gene Therapies, Inc. Filed Acc 0001209191-22-047097
Chief Financial Officer sold 28,675 shares at an average $3.70 ($105,999)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Alam Kamran Chief Financial Officer | 2022-08-18 | Sale | −7,476 | $3.87 | $28,932 | 290,645 | D |
| Alam Kamran Chief Financial Officer | 2022-08-19 | Sale | −11,482 | $3.75 | $43,058 | 279,163 | D |
| Alam Kamran Chief Financial Officer | 2022-08-22 | Sale | −9,717 | $3.50 | $34,010 | 269,446 | D |
| Open-market sales · 28,675 sh · avg $3.70 · $105,999 | |||||||
Loading xslF345X03/doc4.xml…